---
title: "AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294110448.md"
description: "AbbVie Inc. (ABBV) shares rose 2.45% to $263.20, outperforming the broader market and hitting a new 52-week high. While competitors like Pfizer and Amgen also gained, AbbVie's trading volume remained below its 50-day average."
datetime: "2026-07-28T20:32:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294110448.md)
  - [en](https://longbridge.com/en/news/294110448.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294110448.md)
---

# AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of AbbVie Inc. (ABBV) advanced 2.45% to $263.20 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.21% to 7,428.78 and the Dow Jones Industrial Average rising 1.03% to 52,747.32.

AbbVie Inc. hit a new 52-week high, surpassing its previous peak of $262.10, which the company achieved on July 27th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.29% to $266.73, Pfizer Inc. (PFE) rose 2.35% to $25.25, and Amgen Inc. (AMGN) rose 4.48% to $393.10.

Trading volume (6.8 M) remained 183,983 below its 50-day average volume of 7.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 28, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-28-26 1632ET

### Related Stocks

- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Should you buy AbbVie stock hand over fist before July 31?](https://longbridge.com/en/news/293985406.md)
- [AbbVie Inc Stock (ABBV) Moved Up by 3.35% on Jul 28: A Full Analysis](https://longbridge.com/en/news/294086753.md)
- [Bank of Nova Scotia Cuts Stock Position in AbbVie Inc. $ABBV](https://longbridge.com/en/news/293717083.md)
- [AbbVie Inc. $ABBV Shares Bought by Opal Capital LLC](https://longbridge.com/en/news/294190325.md)
- [The Bull Case For AbbVie (ABBV) Could Change Following EU Approval Of Rinvoq For Vitiligo](https://longbridge.com/en/news/294200563.md)